Studies on reduction of azo-linkages in human placental homogenates.
D001391:Azo Compounds / Q000378:metabolism*; D002248:Carbon Monoxide; D004492:Edetic Acid / Q000494:pharmacology; D005260:Female; D005415:Flavins / Q000494:pharmacology; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D005978:Glutathione / Q000494:pharmacology; D006600:Hexosephosphates / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008274:Magnesium / Q000494:pharmacology; D009243:NAD / Q000494:pharmacology; D009249:NADP / Q000378:metabolism / Q000494:pharmacology; D009536:Niacinamide / Q000494:pharmacology; D010100:Oxygen; D010734:Phosphogluconate Dehydrogenase / Q000378:metabolism; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D001391:Azo Compounds; D005415:Flavins; D006600:Hexosephosphates; D013438:Sulfhydryl Compounds; D009243:NAD; D009536:Niacinamide; D009249:NADP; D002248:Carbon Monoxide; D004492:Edetic Acid; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D005978:Glutathione; D008274:Magnesium; D010100:Oxygen